Friday, June 12, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 143 of 1,261
  1. US 11872092

    Methods for surgical guidance in breast cancer surgery and lymph node dissection using two or more implantation devices comprising a capsule and a population of ultrasound-switchable fluorophores incorporated in the capsule

    The Board of Regents of the University of Texas System · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  2. US 11872200

    GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes

    The Regents of the University of California · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  3. US 11873491

    Complement component C5 iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  4. US 11873319

    Cyclic di-nucleotide induction of type I interferon

    The Regents of the University of California · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  5. US 11873296

    Solid forms of a dual RAF/MEK inhibitor

    VERASTEM, INC. · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  6. US 11873490

    Antisense oligomers for treatment of conditions and diseases

    STOKE THERAPEUTICS, INC. · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  7. US 11873350

    Dissolution of oxidized cellulose

    Covidien LP · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  8. US 11872261

    Lipoprotein targeting protease inhibitors and uses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  9. US 11873288

    Inhibitors for soluble epoxide hydrolase (sEH) and fatty acid amide hydrolase (FAAH)

    The Regents of the University of California · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  10. US 11872355

    Medical device for detecting fluid parameters using fluorescent probes

    Covidien LP · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  11. US 11873300

    Crystalline forms of CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  12. US 11872204

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  13. US 11872312

    Neuroprotective liposome compositions and methods for treatment of stroke

    The Board of Regents of the University of Texas System · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  14. US 11872225

    Pyruvate kinase modulators and use thereof

    Agios Pharmaceuticals, Inc. · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  15. US 11872203

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  16. US 11873291

    Quinoline cGAS antagonist compounds

    The Board of Regents of the University of Texas System · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  17. EP 4302751

    ORALE DÜNNFILME MIT GERINGER WASSERAKTIVITÄT

    LTS LOHMANN THERAPIE SYSTEME AG [DE] · Granted Jan 10, 2024 · Expires Jan 5, 2044

    granted
  18. EP 4302750

    ORALE DÜNNFILME ENTHALTEND ADRENALIN

    LTS LOHMANN THERAPIE SYSTEME AG [DE] · Granted Jan 10, 2024 · Expires Jan 5, 2044

    granted
  19. US 11865122

    Estrogen therapy for brain gray matter atrophy and associated disability

    The Regents of the University of California · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  20. US 11866502

    Anti-FGFR2 antibodies and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  21. US 11866476

    Masked IL-2-Fc fusion polypeptides

    Xilio Development, Inc. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  22. US 11866515

    Hemiasterlin derivatives for conjugation and therapy

    Sutro Biopharma, Inc. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  23. US 11866688

    Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  24. US 11865179

    Progesterone formulations having a desirable PK profile

    Compass Therapeutics LLC · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.